L. Connors

655 total citations
7 papers, 476 citations indexed

About

L. Connors is a scholar working on Pharmacology, Organic Chemistry and Surgery. According to data from OpenAlex, L. Connors has authored 7 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 1 paper in Organic Chemistry and 1 paper in Surgery. Recurrent topics in L. Connors's work include Inflammatory mediators and NSAID effects (5 papers), Drug-Induced Adverse Reactions (3 papers) and Fibroblast Growth Factor Research (1 paper). L. Connors is often cited by papers focused on Inflammatory mediators and NSAID effects (5 papers), Drug-Induced Adverse Reactions (3 papers) and Fibroblast Growth Factor Research (1 paper). L. Connors collaborates with scholars based in United States, Mexico and Canada. L. Connors's co-authors include Loren Laine, Thomas J. Schnitzer, Qinfen Yu, Alise Reicin, Christopher J. Hawkey, Claire Bombardier, Sean Curtis, Lawrence Goldkind, Yanqiong Zhang and Amandeep Kaur and has published in prestigious journals such as Journal of Biological Chemistry, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

L. Connors

7 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Connors United States 6 276 143 82 81 72 7 476
Tushar Shukla Canada 7 198 0.7× 205 1.4× 31 0.4× 72 0.9× 134 1.9× 16 535
Lawrence Goldkind United States 10 185 0.7× 105 0.7× 189 2.3× 28 0.3× 23 0.3× 17 581
M F Rack United States 13 548 2.0× 388 2.7× 78 1.0× 139 1.7× 128 1.8× 15 816
Yukiko Yoda Japan 10 125 0.5× 227 1.6× 53 0.6× 32 0.4× 142 2.0× 25 521
Gabriella Pecci Italy 6 187 0.7× 34 0.2× 74 0.9× 66 0.8× 18 0.3× 8 453
Aditi Shahane United States 6 313 1.1× 121 0.8× 30 0.4× 63 0.8× 18 0.3× 11 597
Marcia Poland United States 15 199 0.7× 183 1.3× 49 0.6× 287 3.5× 13 0.2× 33 698
Francesc Riu Spain 10 83 0.3× 68 0.5× 46 0.6× 40 0.5× 17 0.2× 24 489
Geneviève Le Calvez France 8 155 0.6× 271 1.9× 31 0.4× 604 7.5× 139 1.9× 14 905
G.K. van der Hem Netherlands 8 193 0.7× 43 0.3× 86 1.0× 69 0.9× 13 0.2× 11 533

Countries citing papers authored by L. Connors

Since Specialization
Citations

This map shows the geographic impact of L. Connors's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Connors with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Connors more than expected).

Fields of papers citing papers by L. Connors

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Connors. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Connors. The network helps show where L. Connors may publish in the future.

Co-authorship network of co-authors of L. Connors

This figure shows the co-authorship network connecting the top 25 collaborators of L. Connors. A scholar is included among the top collaborators of L. Connors based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Connors. L. Connors is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Shear, Neil H., Morghan Hartmann, Andreas Katsambas, et al.. (2014). Long‐term efficacy and safety of infliximab maintenance therapy in patients with plaque‐type psoriasis in real‐world practice. British Journal of Dermatology. 171(3). 631–641. 29 indexed citations
2.
Laine, Loren, et al.. (2009). How Common Is Diclofenac-Associated Liver Injury? Analysis of 17,289 Arthritis Patients in a Long-Term Prospective Clinical Trial. The American Journal of Gastroenterology. 104(2). 356–362. 85 indexed citations
3.
Swergold, Gary D., James S. McLay, Tim McCarthy, et al.. (2009). Cardiovascular safety and gastrointestinal tolerability of etoricoxib vs diclofenac in a randomized controlled clinical trial (The MEDAL study). Lara D. Veeken. 48(4). 425–432. 58 indexed citations
4.
Laine, Loren, L. Connors, Marie R. Griffin, et al.. (2009). Prescription rates of protective co‐therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelines. Alimentary Pharmacology & Therapeutics. 30(7). 767–774. 37 indexed citations
5.
Laine, Loren, L. Connors, Marie R. Griffin, Sean Curtis, & Christopher P. Cannon. (2008). 117 Physicians Fail to Provide Protective Co-Therapy for High GI Risk Patients Taking NSAIDs—Even with Direct Interactive Communication and Free PPI: Results of a Prospective Outcomes Trial. Gastroenterology. 134(4). A–19. 1 indexed citations
6.
Laine, Loren, L. Connors, Alise Reicin, et al.. (2003). Serious lower gastrointestinal clinical events with nonselective NSAID or coxib use. Gastroenterology. 124(2). 288–292. 247 indexed citations
7.
Mehta, Veela B., L. Connors, Hwa‐Chain Robert Wang, & Ing‐Ming Chiu. (1998). Fibroblast Variants Nonresponsive to Fibroblast Growth Factor 1 Are Defective in Its Nuclear Translocation. Journal of Biological Chemistry. 273(7). 4197–4205. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026